NASDAQ false 0001826011 0001826011 2024-05-15 2024-05-15 0001826011 us-gaap:CommonClassAMember 2024-05-15 2024-05-15 0001826011 us-gaap:WarrantMember 2024-05-15 2024-05-15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 15, 2024

 

 

Banzai International, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39826   85-3118980

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

435 Ericksen Ave, Suite 250

Bainbridge Island, Washington

  98110
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (206) 414-1777

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Class A common stock, par value $0.0001 per share   BNZI   The Nasdaq Global Market
Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50   BNZIW   The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On May 15, 2024, Banzai International, Inc. (the “Company”) issued a press release announcing financial results for the quarter ended March 31, 2024 (the “Press Release”). A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated into this Item 2.02 by reference.

The Press Release includes the Company’s Adjusted EBITDA loss for the three months ended March 31, 2024 and the three months ended March 31, 2023. In addition to the Company’s results determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”), the Company believes that Adjusted EBITDA, a non-GAAP measure as defined below, is useful in evaluating its operational performance distinct and apart from certain irregular, non-cash, and non-operational expenses. The Company uses this information for ongoing evaluation of operations and for internal planning purposes. The Company believes that non-GAAP financial information, when taken collectively with results under GAAP, may be helpful to investors in assessing its operating performance and comparing its performance with competitors and other comparable companies.

Non-GAAP measures should not be considered in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. The Company endeavors to compensate for the limitation of Adjusted EBITDA by also providing the most directly comparable GAAP measure, which is net loss, and a description of the reconciling items and adjustments to derive the non-GAAP measure. Some of these limitations are:

 

   

Adjusted EBITDA does not consider the potentially dilutive impact of stock-based compensation.

 

   

Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditures or contractual commitments.

 

   

Adjusted EBITDA does not reflect impairment and restructuring costs.

 

   

Adjusted EBITDA does not reflect interest expense or other income.

 

   

Adjusted EBITDA does not reflect income taxes.

 

   

Adjusted EBITDA does not reflect audit, legal, incremental accounting and other expenses tied to M&A or the Business Combination.

Other companies, including companies in the Company’s own industry, may calculate Adjusted EBITDA differently from the way it does, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should only be considered alongside results prepared in accordance with GAAP, including various cash-flow metrics, net income (loss) and our other GAAP results and financial performance measures.


Net Income/(Loss) to Adjusted EBITDA Reconciliation

 

($ in Thousands)

   Three Months
Ended
March 31,
2024
     Three Months
Ended
March 31,
2023
     Period-
over-
Period $
    Period-
over-
Period %
 

Net loss

   $ (4,501    $ (3,763    $ (738     19.6

Other income, net

     (4      (63      59       -93.7

Depreciation expense

     2        2        —        0.0

Stock based compensation

     253        402        (149     -37.1

Interest expense

     451        538        (87     -16.2

Interest expense - related party

     578        383        195       50.9

Income tax (benefit) expense

     (1      3        (4     -133.3

GEM commitment fee expense

     200        —         200       nm  

Gain on extinguishment of debt

     (528      —         (528     nm  

Loss on debt issuance

     171        —         171       nm  

Change in fair value of warrant liability

     (408      —         (408     nm  

Change in fair value of warrant liability - related party

     (115      —         (115     nm  

Change in fair value of simple agreement for future equity

     —         23        (23     -100.0

Change in fair value of simple agreement for future equity - related party

     —         303        (303     -100.0

Change in fair value of bifurcated embedded derivative liabilities

     —         32        (32     -100.0

Change in fair value of bifurcated embedded derivative liabilities - related party

     —         137        (137     -100.0

Change in fair value of convertible promissory notes

     544        —         544       nm  

Transaction related expenses*

     1,842        1,251        591       47.2
  

 

 

    

 

 

    

 

 

   

 

 

 

Adjusted EBITDA (Loss)

   $ (1,508    $ (626    $ (882     141.1
  

 

 

    

 

 

    

 

 

   

 

 

 

 

*

Transaction related expenses include

 

($ in Thousands)

   Three Months Ended
March 31,
2024
     Three Months Ended
March 31,
2023
     Period-over-
Period $
    Period-over-
Period %
 

Professional fees - audit

   $ 344      $ 277      $ 67       24.2

Professional fees - legal

     597        68        529       777.9

Incremental accounting

     680        808        (128     -15.8

Market study, M&A support

     221        98        123       125.5
  

 

 

    

 

 

    

 

 

   

 

 

 

Transaction related expenses

   $ 1,842      $ 1,251      $ 591       47.2
  

 

 

    

 

 

    

 

 

   

 

 

 

 

Item 8.01

Other Events.

On May 3, 2024, the Company and YA II PN, Ltd. (“Yorkville”) entered into a Debt Repayment Agreement (the “Debt Repayment Agreement”) with respect to the unsecured promissory note in the principal amount of $2,000,000 issued to Yorkville on December 14, 2023 (the “December Promissory Note”) and the unsecured promissory note in the principal amount of $1,500,000 issued to Yorkville on March 26, 2024 (the “March Promissory Note,” together with the December Promissory Note, the “Promissory Notes”). The Company issued the Promissory Notes pursuant to a Standby Equity Purchase Agreement, dated as of December 14, 2023, by and among Yorkville and the Company, as amended from time to time (the “SEPA”). As of the date hereof, there is an aggregate $2,700,000 outstanding under the Promissory Notes.


Under the Debt Repayment Agreement, Yorkville has agreed that, upon completion of a Company registered offering (the “Offering”) and repayment of an aggregate $2,000,000 outstanding under the Promissory Notes (the “Repayment Amount”), Yorkville will not deliver to the Company any Investor Notice (as defined in the SEPA) and will not exercise its right to convert the remainder of the amount outstanding under the Promissory Notes for a period commencing on the date of the closing of the Offering and ending on the date that is 90 days thereafter. Under the Debt Repayment Agreement, the Company and Yorkville also agreed to extend the maturity date of the Promissory Notes to the date that is 120 days after the closing of the Offering and to satisfy the $200,000 payment premium due in connection with an early redemption through the issuance of an Advance Notice (as defined in the SEPA) for shares of the Company’s Class A common stock, par value $0.0001 per share. The Debt Repayment Agreement is conditioned on the completion of the Offering by June 2, 2024.

The foregoing description of the Debt Repayment Agreement is qualified in its entirety by the full text of such document which is filed as Exhibit 99.2 to this Current Report and incorporated by reference into this Item 8.01.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

Exhibit
No.

  

Description

99.1    Press Release dated May 15, 2024.
99.2    Debt Repayment Agreement, dated as of May 3, 2024, by and among the Company and Yorkville.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 15, 2024

 

BANZAI INTERNATIONAL, INC.
By:  

/s/ Joseph Davy

  Joseph Davy
  Chief Executive Officer